Shanghai Runda Medical Technology Co Ltd
SSE:603108

Watchlist Manager
Shanghai Runda Medical Technology Co Ltd Logo
Shanghai Runda Medical Technology Co Ltd
SSE:603108
Watchlist
Price: 17.39 CNY 0.52% Market Closed
Market Cap: 10.4B CNY
Have any thoughts about
Shanghai Runda Medical Technology Co Ltd?
Write Note

Income Statement

Earnings Waterfall
Shanghai Runda Medical Technology Co Ltd

Revenue
8.4B CNY
Cost of Revenue
-6.2B CNY
Gross Profit
2.2B CNY
Operating Expenses
-1.7B CNY
Operating Income
526.6m CNY
Other Expenses
-486.3m CNY
Net Income
40.3m CNY

Income Statement
Shanghai Runda Medical Technology Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
1 359
N/A
1 420
+5%
1 483
+4%
1 528
+3%
1 629
+7%
1 721
+6%
1 812
+5%
1 948
+7%
2 165
+11%
2 516
+16%
3 029
+20%
3 642
+20%
4 319
+19%
4 855
+12%
5 351
+10%
5 729
+7%
5 964
+4%
6 200
+4%
6 464
+4%
6 821
+6%
7 052
+3%
6 820
-3%
6 700
-2%
6 784
+1%
7 069
+4%
7 834
+11%
8 413
+7%
8 828
+5%
8 860
+0%
8 875
+0%
9 245
+4%
9 721
+5%
10 494
+8%
10 504
+0%
10 255
-2%
9 751
-5%
9 147
-6%
9 042
-1%
8 761
-3%
8 433
-4%
Gross Profit
Cost of Revenue
(999)
(1 043)
(1 086)
(1 106)
(1 188)
(1 265)
(1 333)
(1 421)
(1 557)
(1 811)
(2 174)
(2 620)
(3 104)
(3 520)
(3 897)
(4 169)
(4 325)
(4 537)
(4 732)
(5 017)
(5 139)
(5 030)
(4 956)
(5 013)
(5 158)
(5 715)
(6 121)
(6 454)
(6 468)
(6 541)
(6 858)
(7 154)
(7 564)
(7 563)
(7 338)
(7 073)
(6 729)
(6 689)
(6 477)
(6 245)
Gross Profit
359
N/A
377
+5%
397
+5%
422
+6%
440
+4%
457
+4%
480
+5%
527
+10%
608
+15%
704
+16%
855
+21%
1 022
+19%
1 215
+19%
1 334
+10%
1 454
+9%
1 559
+7%
1 640
+5%
1 663
+1%
1 732
+4%
1 804
+4%
1 913
+6%
1 790
-6%
1 744
-3%
1 771
+2%
1 911
+8%
2 119
+11%
2 292
+8%
2 374
+4%
2 392
+1%
2 335
-2%
2 387
+2%
2 567
+8%
2 931
+14%
2 941
+0%
2 917
-1%
2 678
-8%
2 419
-10%
2 352
-3%
2 284
-3%
2 188
-4%
Operating Income
Operating Expenses
(233)
(240)
(252)
(265)
(287)
(299)
(309)
(336)
(396)
(454)
(541)
(619)
(727)
(764)
(806)
(846)
(907)
(922)
(954)
(974)
(1 086)
(1 099)
(1 097)
(1 131)
(1 179)
(1 253)
(1 362)
(1 430)
(1 460)
(1 477)
(1 514)
(1 619)
(1 910)
(1 887)
(1 912)
(1 856)
(1 683)
(1 700)
(1 668)
(1 661)
Selling, General & Administrative
(213)
(233)
(242)
(255)
(262)
(278)
(288)
(313)
(362)
(432)
(506)
(566)
(671)
(694)
(728)
(770)
(828)
(799)
(842)
(872)
(1 000)
(995)
(992)
(1 022)
(1 063)
(1 174)
(1 276)
(1 333)
(1 293)
(1 359)
(1 392)
(1 500)
(1 724)
(1 745)
(1 769)
(1 709)
(1 484)
(1 550)
(1 521)
(1 521)
Research & Development
(14)
0
0
0
(18)
0
0
0
(25)
0
0
(10)
(34)
0
0
(12)
(39)
(39)
(53)
(55)
(52)
(65)
(69)
(78)
(80)
(99)
(105)
(113)
(113)
(127)
(130)
(141)
(134)
(147)
(153)
(149)
(132)
(144)
(138)
(125)
Depreciation & Amortization
(5)
0
0
0
(7)
0
0
0
(11)
0
0
0
(22)
0
0
0
(39)
0
0
0
(36)
0
0
0
(43)
0
0
0
(65)
0
0
0
(84)
0
0
0
(92)
0
0
0
Other Operating Expenses
(1)
(8)
(10)
(10)
(0)
(21)
(21)
(23)
2
(22)
(35)
(43)
0
(70)
(77)
(64)
(1)
(84)
(59)
(47)
2
(38)
(36)
(31)
7
19
19
16
11
9
8
22
33
6
10
2
25
(7)
(9)
(15)
Operating Income
127
N/A
137
+8%
146
+6%
157
+8%
153
-3%
158
+3%
171
+8%
191
+12%
212
+11%
250
+18%
315
+26%
403
+28%
488
+21%
570
+17%
649
+14%
713
+10%
732
+3%
741
+1%
778
+5%
830
+7%
827
0%
691
-16%
647
-6%
640
-1%
732
+14%
866
+18%
929
+7%
943
+2%
932
-1%
858
-8%
873
+2%
947
+9%
1 021
+8%
1 054
+3%
1 005
-5%
822
-18%
735
-11%
652
-11%
616
-6%
527
-14%
Pre-Tax Income
Interest Income Expense
(31)
(34)
(37)
(39)
(34)
(34)
(32)
(34)
(38)
(41)
(46)
(56)
(105)
(126)
(145)
(155)
(138)
(137)
(135)
(139)
(108)
(100)
(100)
(101)
(95)
(117)
(122)
(134)
(149)
(160)
(170)
(178)
(173)
(200)
(188)
(96)
(168)
(83)
(84)
(173)
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
0
1
1
(2)
(0)
4
6
(16)
9
1
(0)
(42)
2
5
8
7
9
9
5
(5)
1
4
2
(31)
6
8
13
80
9
7
7
Gain/Loss on Disposition of Assets
0
0
0
(0)
(1)
(1)
(1)
0
0
0
0
0
0
0
0
0
(0)
0
0
0
(1)
0
0
0
(1)
0
0
0
(3)
0
0
0
(4)
0
0
0
(3)
0
0
0
Total Other Income
7
7
5
6
8
8
9
6
6
8
7
7
6
5
10
13
14
14
8
8
10
10
8
4
(7)
(10)
(8)
(6)
6
1
8
9
7
8
3
2
12
4
6
2
Pre-Tax Income
103
N/A
110
+7%
113
+3%
125
+10%
126
+1%
132
+5%
147
+11%
162
+11%
180
+11%
217
+21%
277
+28%
356
+28%
387
+9%
449
+16%
518
+15%
577
+11%
592
+3%
626
+6%
652
+4%
698
+7%
686
-2%
604
-12%
561
-7%
551
-2%
636
+15%
748
+18%
808
+8%
809
+0%
780
-4%
700
-10%
715
+2%
780
+9%
820
+5%
869
+6%
828
-5%
742
-10%
656
-12%
582
-11%
544
-6%
362
-34%
Net Income
Tax Provision
(28)
(29)
(30)
(32)
(34)
(35)
(37)
(41)
(48)
(60)
(77)
(98)
(89)
(104)
(120)
(134)
(160)
(173)
(171)
(183)
(175)
(154)
(145)
(132)
(132)
(145)
(156)
(167)
(182)
(171)
(162)
(165)
(165)
(174)
(187)
(180)
(213)
(211)
(211)
(191)
Income from Continuing Operations
75
81
83
92
92
98
110
122
132
157
200
257
297
345
399
444
432
454
480
516
511
450
416
419
504
603
652
642
598
529
553
615
655
695
641
561
443
371
334
171
Income to Minority Interest
0
0
1
(0)
(1)
(3)
(5)
(7)
(16)
(23)
(36)
(58)
(78)
(102)
(131)
(149)
(170)
(181)
(188)
(205)
(202)
(177)
(170)
(166)
(174)
(213)
(227)
(224)
(218)
(201)
(220)
(254)
(237)
(237)
(208)
(166)
(169)
(156)
(144)
(131)
Net Income (Common)
75
N/A
81
+8%
84
+3%
92
+10%
92
0%
95
+3%
105
+11%
115
+10%
116
+1%
134
+15%
164
+23%
199
+21%
219
+10%
242
+11%
267
+10%
295
+10%
262
-11%
273
+4%
292
+7%
311
+6%
310
0%
273
-12%
246
-10%
253
+3%
330
+30%
390
+18%
424
+9%
418
-2%
380
-9%
328
-14%
332
+1%
361
+9%
418
+16%
457
+10%
433
-5%
395
-9%
273
-31%
215
-21%
190
-12%
40
-79%
EPS (Diluted)
0.2
N/A
0.21
+5%
0.22
+5%
0.23
+5%
0.2
-13%
0.18
-10%
0.22
+22%
0.23
+5%
0.23
N/A
0.24
+4%
0.29
+21%
0.34
+17%
0.38
+12%
0.42
+11%
0.46
+10%
0.51
+11%
0.45
-12%
0.47
+4%
0.5
+6%
0.53
+6%
0.53
N/A
0.46
-13%
0.42
-9%
0.43
+2%
0.57
+33%
0.67
+18%
0.73
+9%
0.66
-10%
0.64
-3%
0.55
-14%
0.55
N/A
0.61
+11%
0.7
+15%
0.78
+11%
0.73
-6%
0.67
-8%
0.47
-30%
0.37
-21%
0.29
-22%
0.07
-76%

See Also

Discover More